AKT1 and breast cancer: High circulating levels of IGF-1 are associated with increased risk of PCa and BC [9-11], Moreover, multiple lines of evidence have shown that activation of the PI3K/AKT/mTOR pathway, through insulin/IGF-1 stimulation and/or high levels of essential amino acids, play a crucial role in maintaining the malignant phenotype, and its inhibition antagonizes growth and motility of a range of cancer cells in mouse models [12-17].